Le Lézard
Classified in: Health, Business
Subject: CXP

Post Acute Medical to build innovative behavioral health hospital in Sugar Land, Texas


ENOLA, Pa., June 17, 2020 /PRNewswire/ --Post Acute Medical, LLC (PAM) announced today that it will begin construction on a state-of-the-art, 60-bed behavioral health hospital at 11931 Highway 6, Sugarland, Texas, in mid-July.

Once completed in summer 2021, Voyages of Sugar Land will be PAM's first hospital to integrate inpatient medical and psychiatric care. The Voyages division will join PAM Rehabilitation Hospitals and PAM Specialty Hospitals as part of PAM's Traverse Health System.

"We have come to recognize the importance of an integrated care model for individuals in need of medical and behavioral services who, until now, could not be effectively treated in one setting," says Kristen Smith, PAM's president of Clinical Innovation and Business Intelligence, adding that the expansion of services into behavioral health is an exciting endeavor that aligns with the company's mission and vision. "With this unique model of care, Voyages of Sugar Land will address these patients' comprehensive needs at once, helping them achieve sustainable, long-term health and wellness, while ultimately reducing the cost of care."

When fully operational, Voyages of Sugar Land's 200 employees will serve hundreds of patients through various programs, according to CEO David Montgomery.

"Our integrated team of psychiatrists, internists, psychologists, social workers, and other specialists will provide comprehensive and coordinated short-term care tailored to the needs of each patient," he says. "The main care components will include diagnostic behavioral health evaluation, solution-focused treatment, behavioral strategies that include inpatient and partial hospitalization, medication evaluation and management, intensive outpatient programs, and aftercare planning."

PAM chose Sugar Land, Texas, as the site of its first behavioral health hospital due to the fact that it is recognized nationally as one of the fastest growing and most desired areas for new residents and business developments. With more than 800,000 residents, it is the 10th most populous county in Texas.

About Post Acute Medical, LLC
Post Acute Medical, LLC, (PAM) based in Enola, Pennsylvania, operates Traverse Health System, which provides post-acute health care services through 40 long-term acute care hospitals and medical rehabilitation hospitals, as well as 17 outpatient physical therapy locations, in 12 states. PAM is committed to providing high-quality patient care and outstanding customer service, coupled with loyalty and dedication of highly trained staff, to be the most trusted source for post-acute services in every community it serves. The Voyages division constitutes the organization's behavioral health facilities. Our mission is to serve people by providing compassionate, expert care and to support recovery through education and research. Learn more at www.postacutemedical.com.

SOURCE Post Acute Medical, LLC


These press releases may also interest you

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....

at 10:00
Minister Responsible for Relations with the First Nations and the Inuit Ian Lafrenière today submitted in the National Assembly the third annual report on the administration of the Act to authorize the communication of personal information to the...

at 10:00
Cobb Outpatient Detox has opened a new facility in Marietta, GA, providing outpatient drug and alcohol detox services. The center aims to assist individuals in overcoming addiction while balancing their work and family commitments. Located near major...

at 10:00
A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about...

at 10:00
BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and...

at 10:00
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented...



News published on and distributed by: